secwatch.observer — SEC 8-K summary
======================================

Issuer:     Bionano Genomics, Inc. (BNGO)
CIK:        0001411690
Form:       8-K
Filed at:   2023-04-14T23:59:59+00:00
Accession:  0001140361-23-018454
Event type: other_material
Sentiment:  neutral
Materiality: 0.65
Item codes: 1.01, 5.03, 3.02, 3.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Bionano issues Series A Preferred with 3B votes to Board Chair to facilitate reverse stock split
--------------------------------------------------------------------------------

- Issued one share of Series A Preferred to Chair David Barker for $100; share carries 3,000,000,000 votes.
- Preferred votes only on Reverse Stock Split Proposal, mirroring common stock votes (excluding abstentions and broker non-votes).
- Quorum requirement for stockholder meetings reduced from majority to one-third of outstanding shares.
- Series A Preferred is non-convertible, ranks senior on liquidation, and will be redeemed automatically after reverse split approval.
- Sale exempt under Section 4(a)(2) as accredited investor; shares cannot be transferred without Board consent prior to reverse split vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123018454/0001140361-23-018454-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1411690/000114036123018454/brhc20051350_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-23-018454

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer